SORD anticorps (N-Term)

N° du produit ABIN926669

Détail du produit anti-SORD anticorps

Antigène: SORD (Sorbitol Dehydrogenase (SORD))

Épitope: N-Term

Reactivité: Humain

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp SORD est non-conjugé

Application: Western Blotting (WB)

Purification: Purified

Immunogène: SORD antibody was raised in rabbit using the N terminal of SORD as the immunogen

Information d'application

Indications d'application: Optimal conditions should be determined by the investigator.

Commentaires:

SORD Blocking Peptide, catalog no. 33R-1509, is also available for use as a blocking control in assays to test for specificity of this SORD antibody

Restrictions: For Research Use only

Stockage

Format: Lyophilized

Concentration: Lot specific

Buffer: Lyophilized powder. Add 50 µL of distilled water. Final antibody concentration is 1 mg/mL in PBS buffer.

Conseil sur la manipulation: Avoid repeated freeze/thaw cycles.

Stock: 4 °C/-20 °C

Stockage commentaire: Store at 4 °C, following reconstitution, aliquot and store at -20 °C.

Détails sur SORD

Antigène: SORD (Sorbitol Dehydrogenase (SORD))

Autre désignation: SORD (SORD Produits)

Sujet: Sorbitol dehydrogenase catalyzes the interconversion of polyols and their corresponding ketoses, and together with aldose reductase, makes up the sorbitol pathway that is believed to play an important role in the development of diabetic complications. The first reaction of the pathway (also called the polyol pathway) is the reduction of glucose to sorbitol by ALDR1 with NADPH as the cofactor. SORD then oxidizes the sorbitol to fructose using NAD(+) cofactor. Synonyms: Polyclonal SORD antibody, Anti-SORD antibody, sorbitol dehydrogenase antibody, SORD1 antibody.